Last reviewed: June 22, 2026
Last updated: June 22, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Wegovy, works by slowing stomach emptying and signaling fullness to your brain—a mechanism that typically requires dose escalation over time. Most patients begin at 0.25 mg weekly and titrate upward through a 16-week protocol. PlexusDx delivers compounded semaglutide from licensed 503A pharmacies across all 50 states, with one flat monthly price that doesn't change as your therapeutic dose increases.
How Semaglutide Dosing Works: The Titration Schedule
Semaglutide follows a structured dose escalation pattern designed to help your body adapt while reducing nausea and gastrointestinal side effects. The standard 16-week titration begins at 0.25 mg, then increases by 0.25 mg every four weeks until reaching a maintenance dose, which ranges from 1.7 mg to 2.4 mg weekly for weight loss. This gradual approach allows your GLP-1 receptors to become responsive without overwhelming your system, making tolerability significantly better than starting at higher doses.
Each dose increase happens only if you tolerate the previous level well. Some patients maintain effectiveness at 1.7 mg, while others reach full benefit at 2.0 mg or 2.4 mg—individual variation is normal and expected. Your prescriber monitors your response, side effects, and weight loss progress at each step to determine whether advancing to the next dose tier makes sense for your specific situation.
Typical Semaglutide Dose Ranges for Weight Loss Results
Clinical trials show that semaglutide doses between 1.7 mg and 2.4 mg weekly produce the most meaningful weight loss outcomes in adults with obesity or overweight status plus weight-related conditions. At 2.4 mg weekly, the average patient loses 15% to 22% of their starting body weight over 68 weeks—a benchmark that guided FDA approval for Wegovy. However, meaningful weight loss often begins appearing at lower maintenance doses (1.7 mg to 2.0 mg), and not everyone requires the highest available dose to reach their goals.
The dose that works best for you depends on your metabolic profile, tolerance to side effects, and weight loss trajectory. Some individuals plateau at 1.7 mg with excellent results, while others need to reach 2.4 mg to unlock additional benefit. PlexusDx helps identify your starting dose and escalation path based on your health history and response patterns, ensuring you find the sweet spot between efficacy and tolerability.
Why Semaglutide Pricing Stays Flat Across All Dose Levels
PlexusDx operates on a transparent pricing model where your monthly cost for compounded semaglutide injection remains $149/month flat—regardless of whether you're at 0.25 mg, 1.7 mg, or 2.4 mg. This approach removes the financial barrier many patients face when titrating upward: you never pay more as your therapeutic dose increases. Your dose may need to go up; your price won't.
Compounding from a licensed 503A pharmacy allows PlexusDx to offer this straightforward pricing without membership fees, insurance requirements, or hidden escalators. HSA and FSA accounts are eligible for coverage, making the $149/month investment even more accessible. This flat-fee structure aligns patient incentives with clinical outcomes: you're free to titrate to your optimal dose without worrying that the next step up will cost significantly more.
Personalization Beyond Dose: The Role of Genetic Insights
While dose titration is a cornerstone of semaglutide therapy, genetic variation in your GLP-1 receptor (GLP1R rs6923761) and other peptide-pathway genes influences how quickly you respond and which dose range suits you best. PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month) to map 14 pathways and 49 peptides, revealing whether your genetics favor rapid response or suggest a more gradual titration. Key variants like GIPR rs1800437 and FTO rs9939609 also inform how your body handles appetite signaling and metabolic adaptation.
Understanding your genetic profile helps your PlexusDx prescriber anticipate tolerability challenges and optimize your dose schedule from the start. Patients with certain GLP1R variants may achieve significant weight loss at lower doses, while others benefit from advancing more quickly through the titration ladder. This precision approach transforms generic dosing protocols into a truly personalized plan that respects your unique biology and maximizes the chance of sustained, meaningful weight loss.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the starting dose of semaglutide for weight loss?
The standard starting dose is 0.25 mg injected subcutaneously once weekly. This low initial dose allows your body to acclimate to the medication and reduces the likelihood of nausea or other side effects. After one week at this dose, your prescriber may advance you to the next level based on your tolerance.
How long does it take to reach the full therapeutic dose?
Most patients complete the full titration schedule in 16 weeks, advancing by 0.25 mg every four weeks until reaching their optimal maintenance dose (typically 1.7 mg to 2.4 mg). Some individuals tolerate faster escalation, while others benefit from extended time at each dose level—your prescriber tailors the timeline to your response and comfort.
Does PlexusDx charge more if my dose increases during treatment?
No. PlexusDx compounded semaglutide injections cost a flat $149/month regardless of your dose level. Whether you're starting at 0.25 mg or maintaining at 2.4 mg, the monthly price remains the same, and there are no additional per-dose fees or membership charges.
Are there safety concerns with higher semaglutide doses?
Semaglutide is well-tolerated across the therapeutic dose range when introduced gradually. Common side effects (nausea, vomiting, constipation) typically emerge during titration and often diminish as your body adapts. Serious adverse events are rare, but patients with personal or family history of medullary thyroid cancer or multiple endocrine neoplasia should discuss semaglutide alternatives with their prescriber.
How can genetic testing improve my semaglutide results?
PlexusDx's Precision Peptide Genetic Test identifies variants in your GLP1R, GIPR, FTO, and MC4R genes—each influencing how you respond to semaglutide and at what dose. Patients with certain genetic profiles may achieve excellent results at lower doses or require faster titration; knowing your genetics helps your prescriber personalize your protocol from day one.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Ozempic Dosing Errors: Risks, Symptoms, and What to Do
Navigating Your Path: When is the Best Time to Take a Wegovy® Shot?